Compounds > n,n',n''-tris(2,3-dihydroxy-5-sulfobenzoyl)-1,5,10-triazadecane
Page last updated: 2024-12-08

n,n',n''-tris(2,3-dihydroxy-5-sulfobenzoyl)-1,5,10-triazadecane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N',N''-tris(2,3-dihydroxy-5-sulfobenzoyl)-1,5,10-triazadecane: octahedrally coordinates metal ion via six phenolic oxygens; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID172854
CHEMBL ID3306615
MeSH IDM0096807

Synonyms (9)

Synonym
licam(s)
benzenesulfonic acid, 3-(((4-((2,3-dihydroxy-5-sulfobenzoyl)amino)butyl)(3-((2,3-dihydroxy-5-sulfobenzoyl)amino)propyl)amino)carbonyl)-4,5-dihydroxy-
1,5-n,n',n''-tris(sulfanato-2,3-dihydroxybenzoyl)-1,5,10-triazadecane
n,n',n''-tris(2,3-dihydroxy-5-sulfobenzoyl)-1,5,10-triazadecane
71659-79-5
3,4-licams
DTXSID20221896
CHEMBL3306615
n,n',n''-tris(5-sulfo-2,3-dihydroxybenzoyl)-1,5,10-triazadecane
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (71.43)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.24 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
spermidine
[no description available]		3.3770polyazaalkane;
triamine		autophagy inducer;
fundamental metabolite;
geroprotector
pentetic acid
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.		1.9610pentacarboxylic acidcopper chelator
plutonium
Plutonium: A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, and atomic number 94. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.		2.6530actinoid atom;
f-block element atom
americium
Americium: A completely man-made radioactive actinide with atomic symbol Am, and atomic number 95. Its valence can range from +3 to +6. Because of its nonmagnetic ground state, it is an excellent superconductor. It is also used in bone mineral analysis and as a radiation source for radiotherapy.		1.9610actinoid atom;
f-block element atom
transferrin
Transferrin: An iron-binding beta1-globulin that is synthesized in the LIVER and secreted into the blood. It plays a central role in the transport of IRON throughout the circulation. A variety of transferrin isoforms exist in humans, including some that are considered markers for specific disease states.		2.3720
licam-c
LICAM-C: structure given in first source		2.6530
ConditionIndicatedRelationship StrengthStudiesTrials
Breast Cancer
[description not available]		02.0710
Cancer of Lung
[description not available]		02.0710
Breast Neoplasms
Tumors or cancer of the human BREAST.		02.0710
Lung Neoplasms
Tumors or cancer of the LUNG.		02.0710